Biomarkers for hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Biomarkers for hepatocellular carcinoma.

Biomarkers for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q51595454

about

Differential effects of targeting Notch receptors in a mouse model of liver cancer.Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma.

P2860

Q35660341-B451AE58-1F65-4CB1-82A9-17C51288D3B0 Q37687816-78BF7AF3-70D8-48B0-9832-6D04BD54507C Q46255404-E1B90D59-0979-4E61-B215-9590E72A8554

P2860

Biomarkers for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q51595454

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Biomarkers for hepatocellular carcinoma.

@en

type

label

Biomarkers for hepatocellular carcinoma.

@en

prefLabel

Biomarkers for hepatocellular carcinoma.

@en

P1433

Q51595454-BF437382-1CD6-4BC4-9424-4679567031A4

P1476

Q51595454-6E917AA9-565C-471D-AFE2-554C1FD90607

P2093

Q51595454-3ECCC13B-65BC-40BC-9F74-01FFC5FDA3D8

Q51595454-F20D9879-8FC3-4923-8FD7-F6D077C8FBBB

P2860

Q51595454-02226F99-860C-4668-A939-C70173E58162

Q51595454-0A1D9B6F-B960-4ECF-B16E-9A7D3DA59D17

Q51595454-13683046-439A-4555-8874-F846F3B8ED83

Q51595454-1624BB77-C86A-4CC7-B14E-14722FD9AAC4

Q51595454-16DD4285-409E-4BB9-8CE1-027631AB5F08

Q51595454-1A86511E-42CF-46C3-8FDB-92D89646EBAD

Q51595454-28C23762-5C47-41A0-A1B4-698CD83EB4EB

Q51595454-2CAA07D7-F464-4D5C-8112-6096383ABC24

Q51595454-2E6E750E-605B-4ED8-ABF4-7D26D29F1A12

Q51595454-34BE89A8-660B-4D6C-88E5-6B2FF92B6202

P2888

Q51595454-AE1B5FB6-881D-4897-8E3A-6AF704129FA0

P304

Q51595454-C8493FA1-90C5-4E1A-A697-20CD35669535

P31

Q51595454-EE1813B6-0C3A-4EBE-862C-56C54D1EC1D7

P356

Q51595454-1F6F0401-3856-43D2-83AF-108FBE3B04BC

P433

Q51595454-64CAD481-48A1-4817-AF0D-6C8CECBE4286

P478

Q51595454-EB2E46F6-3D1E-48AF-89DC-9C35C96FF61D

P577

Q51595454-B7225FD1-CEF3-4BA0-954E-A95AA27C0317

P5875

Q51595454-294399A4-87F2-4168-9760-F5D8A945F03B

P698

Q51595454-45ABC2B1-C034-411D-BB5B-3DAE052F0572

P356

S12328-012-0301-X

P1433

Clinical journal of gastroenterology

P1476

Biomarkers for hepatocellular carcinoma.

@en

P2093

Goshi Shiota

http://www.w3.org/2001/XMLSchema#string

Norimasa Miura

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

Role of transforming growth factor beta in human disease

Vitamin K-dependent carboxylase

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.

A novel biomarker TERTmRNA is applicable for early detection of hepatoma.

Present and future possibilities for early diagnosis of hepatocellular carcinoma

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

P2888

s12328-012-0301-x

P304

177-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-012-0301-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233751715

http://www.w3.org/2001/XMLSchema#string

P698

26182317

http://www.w3.org/2001/XMLSchema#string